Insiders · Profile

Quinlan Paul T

General Counsel at Oruka Therapeutics. Filing since 16 Mar 2026. CIK 0001333277

Company
Date
Role
Action
Shares
Amount
Of holding
21 Sep 2026
General Counsel
Sold on a plan
10,000
$936.42K
25.0%
15 Sep 2026
General Counsel
Sold at will
1,039
$99.44K
3.3%
14 Aug 2026
General Counsel
Sold on a plan
52,000
$5.64M
62.6%
15 Jun 2026
General Counsel
Sold at will
733
$51.08K
2.3%
16 Mar 2026
General Counsel
Sold at will
733
$30.27K
2.3%
5 decisions on file.